|
Status |
Public on Jul 19, 2011 |
Title |
AML 2008-012 CD34+ |
Sample type |
RNA |
|
|
Source name |
AML
|
Organism |
Homo sapiens |
Characteristics |
cell type: CD34+ mononuclear disease state: AML
|
Treatment protocol |
Cell were directly sorted after thawing
|
Growth protocol |
Mononuclear cells from AML patients (n=46) were thawed, sorted into CD34+ and CD34- subfractions and genome-wide expression analysis was performed using Illumina BeadChip Arrays (HT12 v3). AML CD34+ and CD34- gene expression was compared to a large group of normal CD34+ bone marrow cells (n=31).
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
|
Label |
biotin
|
Label protocol |
Standard Illumina protocol
|
|
|
Hybridization protocol |
Standard Illumina protocol
|
Scan protocol |
Illumina i-Scan reader
|
Description |
2008-012 CD34+ 4811636082_E
|
Data processing |
The data were normalised using quantile normalisation with IlluminaGUI in R
|
|
|
Submission date |
Jun 16, 2011 |
Last update date |
Jul 19, 2011 |
Contact name |
JJ Schuringa |
E-mail(s) |
[email protected]
|
Organization name |
UMCG
|
Department |
Experimental Hematology
|
Street address |
Hanzeplein 1
|
City |
Groningen |
ZIP/Postal code |
9700RB |
Country |
Netherlands |
|
|
Platform ID |
GPL6947 |
Series (1) |
GSE30029 |
Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML |
|